Nektar Therapeutics (NKTR) Stock buybacks 2023–2025
Nektar Therapeutics (NKTR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2025 · since FY2023: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $3.0M | — |
| FY2023 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NKTR financial trends
NKTR RevenueNKTR Net incomeNKTR Net marginNKTR Gross profitNKTR Gross marginNKTR Operating incomeNKTR Operating marginNKTR Operating cash flowNKTR Free cash flowNKTR Capital expendituresNKTR Return on equityNKTR Dividends paidNKTR Total assetsNKTR Total liabilitiesNKTR Shareholders’ equityNKTR overview →